News and updates from across the LGC Group

Aristea Anna Leventi is currently completing a PhD between the University of Strathclyde and the National Measurement Laboratory on quantitative bioimaging for cancer diagnostics and biomarker detection.

Contributed to advice from Advisory Council on Misuse of Drugs

Second successive year that we have been awarded the most family-friendly / work-life-balance-oriented employer in the southeast area of Berlin

Renewal of GMOs and feed additives NRL functions supplemented by awarding of new Authorisations roles

From January 2022, the electricity we purchase for five of our sites in Germany - Augsburg, Berlin, Kulmbach, Luckenwalde and Wesel - will be generated from 100% renewable sources.

From January 2022, the electricity we purchase for five of our sites in Germany - Augsburg, Berlin, Kulmbach, Luckenwalde and Wesel - will be generated from 100% renewable sources.

LGC has co-sponsored a new Chair in Measurement Science at the University of Strathclyde in Glasgow, UK, to help advance innovation in the medical, food and drink, and high-value manufacturing industries in the UK.

Update for the half year ended 30 September 2021

Site will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics

Site will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics

LGC is committing to being carbon net zero by 2050

LGC’s MHRA Laboratories Team supports the annual BP publication by providing physico-chemical analysis of substances